-
1
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
The SOLVD investigators
-
The SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N. Engl. J. Med. 325 1991 293 302
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 293-302
-
-
-
2
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
-
The CONSENSUS trial study group
-
The CONSENSUS trial study group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N. Engl. J. Med. 316 1987 1429 1435
-
(1987)
N. Engl. J. Med.
, vol.316
, pp. 1429-1435
-
-
-
3
-
-
0026786643
-
Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
-
The SAVE investigators
-
The SAVE investigators Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial N. Engl. J. Med. 327 1992 669 677
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 669-677
-
-
-
4
-
-
0027423378
-
Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
-
The AIRE study investigators
-
The AIRE study investigators Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
-
(1993)
Lancet
, vol.342
, pp. 821-828
-
-
-
5
-
-
9044239676
-
A Clinical trial of the angiotensin-converting-enzyme inhibitor trandalopril in patients with left ventricular dysfunction after myocardial infarction
-
Trandalopril Cardiac Evaluation (TRACE) Study Group
-
Trandalopril Cardiac Evaluation (TRACE) Study Group A Clinical trial of the angiotensin-converting-enzyme inhibitor trandalopril in patients with left ventricular dysfunction after myocardial infarction N. Engl. J. Med. 333 1995 1670 1676
-
(1995)
N. Engl. J. Med.
, vol.333
, pp. 1670-1676
-
-
-
6
-
-
0028273258
-
GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'ìnfarto Miocardico
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'ìnfarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
-
(1994)
Lancet
, vol.343
, pp. 1115-1122
-
-
-
7
-
-
0034688194
-
Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
The Heart Outcomes Prevention and Evaluation Investigators
-
The Heart Outcomes Prevention and Evaluation Investigators Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N. Engl. J. Med. 342 2000 145 153
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 145-153
-
-
-
8
-
-
0022651005
-
Effect of vasoactive peptides on prostacyklin synthesis in man
-
S.E. Barrow, C.T. Dollery, D.J. Heavey, N.E. Hickling, J.M. Ritter, and J. Vial Effect of vasoactive peptides on prostacyklin synthesis in man Br. J. Pharmacol. 1986 243 247
-
(1986)
Br. J. Pharmacol.
, pp. 243-247
-
-
Barrow, S.E.1
Dollery, C.T.2
Heavey, D.J.3
Hickling, N.E.4
Ritter, J.M.5
Vial, J.6
-
9
-
-
0015237292
-
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
-
J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature 231 1971 232 235
-
(1971)
Nature
, vol.231
, pp. 232-235
-
-
Vane, J.R.1
-
10
-
-
0034701974
-
Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
-
T. Stys, W.E. Lawson, G.C. Smaldone, and A. Stys Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure? Arch. Intern. Med. 160 2000 1409 1413
-
(2000)
Arch. Intern. Med.
, vol.160
, pp. 1409-1413
-
-
Stys, T.1
Lawson, W.E.2
Smaldone, G.C.3
Stys, A.4
-
11
-
-
0031567879
-
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II
-
K.N. Nguyen, I. Aursnes, and J. Kjekshus Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II Am. J. Cardiol. 79 1997 115 119
-
(1997)
Am. J. Cardiol.
, vol.79
, pp. 115-119
-
-
Nguyen, K.N.1
Aursnes, I.2
Kjekshus, J.3
-
12
-
-
0031955764
-
Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
-
A.S. Al-Khadra, D.N. Salem, W.M. Rand, J.E. Udelson, J.J. Smith, and M.A. Konstam Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial J. Am. Coll. Cardiol. 31 1998 419 425
-
(1998)
J. Am. Coll. Cardiol.
, vol.31
, pp. 419-425
-
-
Al-Khadra, A.S.1
Salem, D.N.2
Rand, W.M.3
Udelson, J.E.4
Smith, J.J.5
Konstam, M.A.6
-
13
-
-
0033501437
-
Meeting report: LIDO, HOPE, MOXCON, and WASH studies
-
C.G. Jones, and J.G.F. Cleland Meeting report: LIDO, HOPE, MOXCON, and WASH studies Eur. J. Heart Fail. 1 1999 425 431
-
(1999)
Eur. J. Heart Fail.
, vol.1
, pp. 425-431
-
-
Jones, C.G.1
Cleland, J.G.F.2
-
14
-
-
0038494006
-
Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure
-
M. Guazzi, R. Brambilla, G. Rèina, G. Tumminello, and M.D. Guazzi Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure Arch. Intern. Med. 163 2003 1574 1579
-
(2003)
Arch. Intern. Med.
, vol.163
, pp. 1574-1579
-
-
Guazzi, M.1
Brambilla, R.2
Rèina, G.3
Tumminello, G.4
Guazzi, M.D.5
-
15
-
-
0029119154
-
Is aspirin safe for patients with heart failure?
-
J.G. Cleland, C.J. Bulpitt, R.H. Falk, I.N. Findlay, C.M. Oakley, and G. Murray Is aspirin safe for patients with heart failure? Br. Heart J. 74 1995 215 219
-
(1995)
Br. Heart J.
, vol.74
, pp. 215-219
-
-
Cleland, J.G.1
Bulpitt, C.J.2
Falk, R.H.3
Findlay, I.N.4
Oakley, C.M.5
Murray, G.6
-
16
-
-
0036228408
-
Is aspirin "the Weakest Link" in cardiovascular prophylaxis? the surprising lack of evidence supporting the use of aspirin for cardiovascular disease
-
J.G.F. Cleland Is aspirin "The Weakest Link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease Prog. Cardiovasc. Dis. 44 2002 275 292
-
(2002)
Prog. Cardiovasc. Dis.
, vol.44
, pp. 275-292
-
-
Cleland, J.G.F.1
-
17
-
-
0034755239
-
Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?
-
D. Hall Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure? Cardiol. Clin. 19 2001 597 603
-
(2001)
Cardiol. Clin.
, vol.19
, pp. 597-603
-
-
Hall, D.1
-
19
-
-
8144227308
-
Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors
-
(In press).
-
Juhlin T, Björkman S, Gunnarsson B, Fyge Å, Roth B, Höglund P, Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors. Eur. J. Heart Fail., (In press).
-
Eur. J. Heart Fail.
-
-
Juhlin, T.1
Björkman, S.2
Gunnarsson, B.3
Fyge, Å.4
Roth, B.5
Höglund, P.6
-
20
-
-
0034125647
-
Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice
-
N. Moore, X. Verschuren, C. Montout, J. Callens, S.X. Kong, and B. Bégaud Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice Thérapie 55 2000 133 136
-
(2000)
Thérapie
, vol.55
, pp. 133-136
-
-
Moore, N.1
Verschuren, X.2
Montout, C.3
Callens, J.4
Kong, S.X.5
Bégaud, B.6
-
21
-
-
0343184105
-
Consumption of NSAIDs and the development of congestive heart failure in elderly patients. An underrecognised public health problem
-
J. Page, and D. Henry Consumption of NSAIDs and the development of congestive heart failure in elderly patients. An underrecognised public health problem Arch. Intern. Med. 160 2000 777 784
-
(2000)
Arch. Intern. Med.
, vol.160
, pp. 777-784
-
-
Page, J.1
Henry, D.2
-
22
-
-
0032565606
-
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics
-
E.R. Heerdink, H.G. Leufkens, R.M. Herings, J.P. Ottervanger, B.H. Stricker, and A. Bakker NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics Arch. Intern. Med. 158 1998 1108 1112
-
(1998)
Arch. Intern. Med.
, vol.158
, pp. 1108-1112
-
-
Heerdink, E.R.1
Leufkens, H.G.2
Herings, R.M.3
Ottervanger, J.P.4
Stricker, B.H.5
Bakker, A.6
-
23
-
-
0024561510
-
Peripheral hemodynamic effects of captopril in patients with congestive heart failure
-
H. Nishimura, S. Kubo, M. Ueyama, J. Kubota, and K. Kawamura Peripheral hemodynamic effects of captopril in patients with congestive heart failure Am. Heart J. 117 1989 100 105
-
(1989)
Am. Heart J.
, vol.117
, pp. 100-105
-
-
Nishimura, H.1
Kubo, S.2
Ueyama, M.3
Kubota, J.4
Kawamura, K.5
-
24
-
-
0025726483
-
Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
-
G.A. Riegger, H.W. Kahles, D. Elsner, E.P. Kromer, and K. Kochsiek Effects of acetylsalicylic acid on renal function in patients with chronic heart failure Am. J. Med. 90 1991 571 575
-
(1991)
Am. J. Med.
, vol.90
, pp. 571-575
-
-
Riegger, G.A.1
Kahles, H.W.2
Elsner, D.3
Kromer, E.P.4
Kochsiek, K.5
-
25
-
-
0026754776
-
Angiotensin-converting enzyme inhibitors and renal function in heart failure
-
R. Dietz, F. Nagel, and K.J. Osterziel Angiotensin-converting enzyme inhibitors and renal function in heart failure Am. J. Cardiol. 70 1992 119C 125C
-
(1992)
Am. J. Cardiol.
, vol.70
-
-
Dietz, R.1
Nagel, F.2
Osterziel, K.J.3
-
26
-
-
0035899896
-
Renal considerations in angiotensin converting enzyme inhibitors therapy
-
A.C. Schoolwerth, D.A. Sica, B.J. Ballermann, and C.S. Wilcox Renal considerations in angiotensin converting enzyme inhibitors therapy Circulation 104 2001 1985 1991
-
(2001)
Circulation
, vol.104
, pp. 1985-1991
-
-
Schoolwerth, A.C.1
Sica, D.A.2
Ballermann, B.J.3
Wilcox, C.S.4
-
27
-
-
0031723691
-
Renal hemodynamics effects in patients with moderate to severe heart failure during chronic treatment with trandolapril
-
M. van der Ent, W.J. Remme, P.W. de Leeuw, and G.L. Bartels Renal hemodynamics effects in patients with moderate to severe heart failure during chronic treatment with trandolapril Cardiovasc. Drugs Ther. 12 1998 395 403
-
(1998)
Cardiovasc. Drugs Ther.
, vol.12
, pp. 395-403
-
-
Van Der Ent, M.1
Remme, W.J.2
De Leeuw, P.W.3
Bartels, G.L.4
-
28
-
-
0034636845
-
Renal function, neurohormonal activation and survival in patients with chronic heart failure
-
H.L. Hillege, A.RJ. Girbes, P.J. de Kam, F. Boosma, D. de Zeeuv, and A. Charlesworth Renal function, neurohormonal activation and survival in patients with chronic heart failure Circulation 102 2000 203 210
-
(2000)
Circulation
, vol.102
, pp. 203-210
-
-
Hillege, H.L.1
Girbes, A.R.J.2
De Kam, P.J.3
Boosma, F.4
De Zeeuv, D.5
Charlesworth, A.6
-
29
-
-
0036023204
-
The prognostic importance of different definitions of worsening renal function in congestive heart failure
-
S.S. Gottlieb, W. Abraham, J. Butler, D.E. Forman, E. Loh, and B.M. Massie The prognostic importance of different definitions of worsening renal function in congestive heart failure J. Card. Fail. 8 2002 136 141
-
(2002)
J. Card. Fail.
, vol.8
, pp. 136-141
-
-
Gottlieb, S.S.1
Abraham, W.2
Butler, J.3
Forman, D.E.4
Loh, E.5
Massie, B.M.6
-
30
-
-
0036124855
-
Influence of progressive renal dysfunction in chronic heart failure
-
A.P. Maxwell, H.Y. Ong, and D.P. Nicholls Influence of progressive renal dysfunction in chronic heart failure Eur. J. Heart Fail. 4 2002 125 130
-
(2002)
Eur. J. Heart Fail.
, vol.4
, pp. 125-130
-
-
Maxwell, A.P.1
Ong, H.Y.2
Nicholls, D.P.3
-
31
-
-
0024324540
-
Captopril and the diuretic requirements in moderate and severe chronic heart failure
-
O. Odemuyiwa, D. Gilmartin, D. Kenny, and R.J.C. Hall Captopril and the diuretic requirements in moderate and severe chronic heart failure Eur. Heart J. 10 1989 586 590
-
(1989)
Eur. Heart J.
, vol.10
, pp. 586-590
-
-
Odemuyiwa, O.1
Gilmartin, D.2
Kenny, D.3
Hall, R.J.C.4
-
32
-
-
0019596906
-
Kinin-induced prostaglandin synthesis by renal papillary collecting tubule cells in culture
-
F.C. Grenier, T.E. Rollins, and W.L. Smith Kinin-induced prostaglandin synthesis by renal papillary collecting tubule cells in culture Am. J. Physiol. 241 1981 F94 F104
-
(1981)
Am. J. Physiol.
, vol.241
-
-
Grenier, F.C.1
Rollins, T.E.2
Smith, W.L.3
-
33
-
-
26644473077
-
Renal effects of different doses of acetylsalicylic acid in overhydrated healthy volunteers with activated renin angiotensin system
-
T. Juhlin, and P. Höglund Renal effects of different doses of acetylsalicylic acid in overhydrated healthy volunteers with activated renin angiotensin system Eur. Heart J. 24 Suppl. S 2003 (Aug-Sep) 404
-
(2003)
Eur. Heart J.
, vol.24
, Issue.SUPPL. S
, pp. 404
-
-
Juhlin, T.1
Höglund, P.2
|